A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2011
10/18/2011	US8039464 Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2469459C Methods and compositions for the diagnosis of asthma
10/18/2011	CA2466906C Pharmaceutical composition comprising a prostaglandin e1
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2372099C Antiviral agent in the form of nose drops
10/13/2011	WO2011127170A2 Methods for diagnosing and treating asthma
10/13/2011	WO2011125086A1 Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
10/13/2011	WO2011124930A1 P38 map kinase inhibitors
10/13/2011	WO2011124923A2 Novel compounds
10/13/2011	WO2011124525A1 Combinations of medicaments, containing pde4 inhibitors and ep4 receptor antagonists
10/13/2011	WO2011124524A1 Combinations of medicaments, containing pde4 inhibitors and ep4 receptor antagonists
10/13/2011	WO2011124493A1 Composition containing components of echinacea, elder, and chamomile for treating common colds
10/13/2011	WO2011123945A1 Compostions, methods and uses for treating respiratory syncytial virus infection
10/13/2011	WO2011071296A3 Anti-inflammatory pharmaceutical composition comprising extracts from broussonetia papyrifera and lonicera japonica
10/13/2011	WO2011038086A3 Indolizine inhibitors of 5-lipoxygenase
10/13/2011	US20110251286 Crystalline salts and/or co-crystals of O-desmethyltramadol
10/13/2011	US20110251283 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/13/2011	US20110251260 NOVEL siRNAS AND METHODS OF USE THEREOF
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251244 Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient
10/13/2011	US20110251234 Mesylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta2 adrenergic receptor
10/13/2011	US20110251226 Cyclohexylamin isoquinolone derivatives
10/13/2011	US20110251224 Spiro-oxindole compounds and their uses as therapeutic agents
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251211 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251205 Squaramide derivatives as cxcr2 antagonist
10/13/2011	US20110251197 Lysosomotropic inhibitors of acid ceramidase
10/13/2011	US20110251192 Amide compounds, their pharmaceutical compositions, their preparation method and their uses
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251166 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251164 Carboxamide Derivatives As Muscarinic Receptor Antagonists
10/13/2011	US20110251157 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
10/13/2011	US20110251142 Use of triterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of upper respiratory apparatus for the treatment of the effects resulting from the upper respiratory tract diseases
10/13/2011	US20110251136 Glue composition for lung volume reduction
10/13/2011	US20110250300 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
10/13/2011	US20110250281 Fexofenadine Microcapsules and Compositions Containing Them
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250242 Arformoterol and tiotropium compositions and methods for use
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250206 Markers for determination of patient responsiveness
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250190 Pharmaceutical preparation
10/13/2011	CA2800514A1 Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374508A1 Combination of angiotension receptor blockers (ARB) and NSAIDs for use in ameliorating cachexia
10/12/2011	EP2374458A1 Combination of an ACE inhibitor and an NSAID for use in ameliorating cachexia/SIRS
10/12/2011	EP2374456A1 Activated blood coagulation factor x (fxa) inhibitor
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2373998A1 Nitroprotein biomarkers for copd
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP2373628A1 Novel compounds
10/12/2011	EP2373311A1 Inhibitors of hif-1 protein accumulation
10/12/2011	EP2373307A1 Novel use of fibrates
10/12/2011	EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	CN202005899U Double-circular-table angle-lap-shaped traditional Chinese medicine tablet with wrapper for treating inflammation of mouth cavity and throat part
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216300A Compounds and compositions as protein kinase inhibitors
10/12/2011	CN102216273A Naphthylacetic acids used as crth2 antagonists or partial agonists
10/12/2011	CN102216265A Naphthylacetic acids
10/12/2011	CN102216249A Naphthylacetic acids
10/12/2011	CN102215849A Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
10/12/2011	CN102215844A Folate receptor binding conjugates of antifolates
10/12/2011	CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
10/12/2011	CN102212068A Thiofuran derivative, preparation method thereof and application thereof in medicaments
10/12/2011	CN102212062A Derivative of amino ester, salt thereof and using method
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210912A New artificial health-care plastic respiratory mask capable of preserving body health and preventing and curing diseases
10/12/2011	CN102210824A Chinese medicinal preparation for treating mycoplasmal pneumonia of swine
10/12/2011	CN102210819A Medicament for treating anemopyretic cold and preparation method thereof
10/12/2011	CN102210816A Traditional Chinese medicine for treating radiation pneumonia
10/12/2011	CN102210813A Traditional Chinese medicine composition for diminishing inflammation and relieving toxicity for livestock and poultry and preparation method thereof
10/12/2011	CN102210808A Method for preparing Chinese medicinal composition for treating infantile pharyngitis
10/12/2011	CN102210805A Medicament for dispersing pathogenic wind and relieving cough and preparation method thereof
10/12/2011	CN102210793A Traditional Chinese medicine composition for treating cold and preparation method thereof
10/12/2011	CN102210776A Medicament for treating common cold, and preparation method thereof
10/12/2011	CN102210773A Chinese medicinal cataplasm for treating infantile pneumonia, preparation method thereof and application thereof
10/12/2011	CN102210765A Orally-taken Chinese medical decoction for treating lung meridian wind-heat type nasosinusitis
10/12/2011	CN102210748A Preparation method of Keke preparation
10/12/2011	CN102210744A Anti-virus infection traditional Chinese medicine composition
10/12/2011	CN102210737A Sweet potato leaf extract and preparation method and use thereof
10/12/2011	CN102210718A Method for preparing composite-probiotic-fermented Chinese herbal medicine
10/12/2011	CN102210688A Compound methoxyphenamine quick-release and sustained-release preparation
10/12/2011	CN102210687A Compound methoxyphenamine sustained release preparation
10/12/2011	CN102210673A Cyclodextrin inclusion compound containing ligustilide, and preparation method thereof
10/12/2011	CN102210666A Medical use of salvianolic acid A
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN101972441B Medicament for treating cough and asthma and preparation method thereof
10/12/2011	CN101850093B Medicinal composition for treating hyperplasia of mammary glands
10/12/2011	CN101822845B Genomic medicine for inhabiting lung cancer transfer and pulmonary metastatic tumor
10/12/2011	CN101659954B Recombinant adenovirus expressing mycoplasma hyopneumoniae P102 protein and applications thereof

1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 878